Couple embracing

Leading Pituitary Cancer Care Close to Home

Providence provides pioneering, integrated, advanced treatment options for every type and stage of pituitary cancer, conveniently located at our leading-edge cancer treatment centers. We fight your cancer diagnosis with the latest therapies and pituitary cancer treatments, taking a patient-centric approach to your overall health and well-being.

We understand that your pituitary cancer diagnosis is different from someone else's. A personalized care team is established just for you and will meet regularly to discuss your individualized treatment plan and evaluate every step in your fight against cancer. Our nurse navigators help lead the way, answering your questions and coordinating integrative care and support services.

Why Choose Us for Brain and Nervous System Cancer Care?

At Providence, we see the life in you. Together, let’s finish cancer – so you don’t have to miss any of life’s special moments.

No two patients, or their treatment plans, are alike. This is why, at Providence, we take a highly personalized approach to your brain and nervous system cancer care. You’ll experience this through our multidisciplinary tumor boards, where your oncology team collaborates with other cancer care experts about your specific diagnosis. We also offer a Providence Molecular Tumor Board, where we evaluate your genomic and clinical information to find the best genetically matched treatment for you. Your oncology team will work with you directly to design a treatment plan that fits your personal needs. It’s an approach that combines leading-edge treatment with the compassionate care Providence is known for. Why? Because we know this results in the best outcomes.

As a patient, you’ll be supported through your entire cancer journey by a multidisciplinary cancer care team. You’ll be treated by neuro-oncologists and radiation oncologists, who may use Gamma Knife technology to precisely target tumors with high-dose radiation beams, a procedure known as stereotactic radiosurgery. If surgery is required, our experienced world-class neurosurgeons use the most advanced and minimally invasive techniques. This may include neuroendoscopy or open surgical resection. It’s a team-based approach to brain and nervous cancer care. Your care team may include cancer rehabilitation specialists, oncology nurse navigators and other cancer specialists. We also provide you and your family with a full range of support services well beyond conventional treatment, from genetic counseling and education to nutrition and pain management.

Learn more about the experts who make up our multidisciplinary cancer care teams.

Cancer doesn’t discriminate, but access to great brain and nervous system cancer care hasn’t always been the same for everyone. At Providence, we are deeply committed to making sure every patient we treat has access to the best cancer care. We offer various location-specific services to help our patients receive equitable care, such as translation for non-English-speaking patients, telehealth and transportation assistance. We value, respect and support the racial, ethnic, religious, gender, sexual and spiritual identities of each member of our diverse communities, and we welcome all patients, regardless of their ability to pay. We aim to make sure every patient is treated equally and with dignity – whoever you are, and wherever you’re at.

As a patient at Providence, you have access to the largest community-based cancer network in the United States. Being part of a collaborative network means that your local brain and nervous system cancer care team shares knowledge and experience with other world-class clinicians across 51 hospitals in seven states. The extent and power of our network is one of the reasons more than 2,500 new brain and nervous system cancer patients, and 50,000 new cancer patients, choose Providence each year.

Providence is well known for offering options – and hope – to patients seeking the most advanced procedures and therapies to treat brain and nervous system cancers. As a patient, you have the opportunity to participate in one of the many clinical trials for brain tumors happening across the Providence network, including a study on immunotherapy drugs for recurrent glioblastoma.

Our Approach

Our approach is unique. We take a patient-centric, holistic approach to your overall health and well-being by treating your cancer diagnosis with the most effective and advanced pituitary cancer treatments available. Our research-based treatment plans are tailored to each patient's unique type and stage of pituitary cancer.

Our highly trained, compassionate oncologists and clinicians bring years of expertise and world-class knowledge to your pituitary cancer care. Our cancer doctors are among the top cancer specialists in the country, so you know you are getting the best care possible.

Providence's pituitary cancer treatment centers provide patients with the most effective treatment options. Our wide range of pituitary cancer therapy options include chemotherapy, radiation, pituitary tumor surgery, and targeted therapies. We also offer access to the most advanced therapy options through clinical trials, ensuring that the latest treatments are available to you.

Pituitary Cancer Care Locations

Meet the Team

At Providence, you'll have access to a vast network of dedicated and compassionate providers who offer personalized care by focusing on treatment, prevention and health education.

Contact Us

Expert Tips and Advice for Cancer

9/22/2023
Providence Swedish is at the forefront of new technologies that decrease pain and shorten recovery time for prostate cancer patients.
9/22/2023
Providence Cancer Institute of Oregon announces new division director and deputy director of Hematology and Medical Oncology.
9/13/2023
While rates of lung cancer have dropped with successful campaigns to curb smoking, lung cancer remains a problem – including for non-smokers. Learn how.
9/18/2023
For Gynecologic Cancer Awareness Month, Providence Cancer Institute highlights a clinical trial that evaluates the safety and effectiveness of a new oral treatment for grade 1 endometrial cancer.